Мать и Дитя MDMG

Quarterly report 2026-Q2
added 10-04-2026

Мать и Дитя Financial Ratios 2025-2011 | MDMG

Brief overview of Мать и Дитя's financial ratios

This overview follows the five latest available observations from 2021 through 2025.

The latest available valuation ratios are P/E 10x (median 7x), EV/EBITDA 8x (median 6x), P/S 3x (median 2x). Valuation is 42.9% above five-year reference levels. The premium requires support from earnings and returns.

Earnings yield calculated as 1/P/E is about 10%, showing current profit per unit of share price.

End-period return metrics are ROE 29.5%, ROA 21.7%, ROCE 36.7%. Current resource returns are convincing and help explain a higher market valuation.

On PEG (0.77x), valuation is restrained relative to growth, but one ratio cannot replace cash-flow and risk analysis.

Liquidity is near a workable range, with a 1.46x current ratio and 1.19x quick ratio.

At 0.03x debt/equity, interest expense is covered 13.1x. Financial leverage is conservative.

The cash conversion cycle shortened from -28 days to -38.1 days, or 10.1 days. Working capital returns faster.

Overall picture

Мать и Дитя's profitability supports higher multiples, although much of the quality is already reflected in price.

Annual Financial Ratios Мать и Дитя

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Price Earnings Ratio, P/E	10	7	7	6.81	9.96	8.08	8.8	8.79	18.32	21.09	17.51	20.44	43.87	19632.67	28.22
Price Sales Ratio, P/S	3	2	2	1.23	2.37	1.77	1.44	1.57	3.32	3.58	2.95	3.39	4.92	6765.38	8.35
Price To Book Ratio, P/B	4	2	2	1.16	2.62	1.73	1.32	1.5	3.22	3.53	2.53	2.51	3.17	3317.19	9.41
Price Earnings To Growth Ratio, PEG	0.77	-	-	-0.28	0.23	0.14	-6.27	1.23	0.89	0.73	0.51	0.23	-0.72	350.84	0.0
Operating Cash Flow Per Share	185.09	147.8	124.9	102.94	113.14	86.73	65.84	55.59	55.89	51.55	37.63	28.07	21.42	0.03	17.21
Free Cash Flow Per Share	134	128	80	87.38	62.68	34.75	12.69	6.35	9.66	28.22	27.11	-13.7	-10.95	-0.01	-11.79
Cash Per Share	36.35	80.56	131.69	59.4	47.78	51.58	47.5	36.2	33.44	21.94	23.69	11.87	43.6	0.07	2.14
Payout Ratio	0.62	2	-	0.14	0.45	0.53	0.3	0.19	0.27	0.38	0.19	0.15	0.49	0.11	0.0
Dividend Yield	0.06	0.23	-	0.02	0.05	0.07	0.03	0.02	0.01	0.02	0.01	0.01	0.01	0.0	0.0
Current Ratio	-	-	-	1.46	0.9	1.04	1.19	1.05	1.01	0.77	0.82	0.56	1.79	3.62	0.28
Quick Ratio	-	-	-	1.19	0.72	0.87	1.01	0.87	0.86	0.63	0.71	0.46	1.74	3.58	0.25
Cash Ratio	-	-	-	0.99	0.56	0.55	0.73	0.75	0.73	0.5	0.6	0.35	1.66	1.76	0.16
Days Of Sales Outstanding, DSO	-	-	-	-	-	-	-	-	11.18	-	-	-	-	-	-
Days Of Inventory Outstanding, DIO	-	-	-	28.68	27.91	29.61	25.33	25.9	22.94	21.96	20.19	23.12	11.95	9.15	6.75
Days Of Payables Outstanding, DPO	-	-	-	66.77	72.13	79.96	61.04	53.88	58.18	56.81	53.87	77.54	80.55	137.0	79.92
Operating Cycle	-	-	-	28.68	27.91	29.61	25.33	25.9	34.12	21.96	20.19	23.12	11.95	9.15	6.75
Cash Conversion Cycle	-	-	-	-38.09	-44.22	-50.35	-35.72	-27.98	-24.06	-34.85	-33.68	-54.43	-68.61	-127.85	-73.17
Gross Profit Margin	-	-	-	0.39	0.4	0.37	0.36	0.37	0.39	0.39	0.38	0.41	0.4	0.5	0.5
Operating Profit Margin	0.25	0.28	0.27	0.2	0.26	0.24	0.19	0.21	0.23	0.22	0.19	0.21	0.2	0.38	0.41
Pretax Profit Margin	0.25	0.3	0.28	0.19	0.24	0.23	0.17	0.19	0.2	0.18	0.19	0.19	0.15	0.37	0.41
Net Profit Margin	0.25	0.3	0.28	0.18	0.24	0.22	0.16	0.18	0.18	0.17	0.17	0.17	0.11	0.34	0.3
Effective Tax Rate	-	-	-	0.0	0.0	0.0	-0.01	0.01	0.03	-0.02	0.02	0.05	0.09	-0.01	0.23
Return On Assets, ROA	0.22	0.26	0.19	0.14	0.18	0.13	0.09	0.11	0.11	0.11	0.09	0.07	0.05	0.11	0.18
Return On Equity, ROE	0.29	0.33	0.23	0.17	0.26	0.21	0.15	0.17	0.18	0.17	0.14	0.12	0.07	0.17	0.33
Return On Capital Employed, ROCE	0.37	0.32	0.23	0.17	0.24	0.17	0.13	0.15	0.17	0.18	0.12	0.11	0.1	0.14	0.3
Net Income Per Ebt	1.0	1.0	1.0	0.96	0.97	0.97	0.96	0.93	0.89	0.92	0.89	0.86	0.76	0.92	0.72
Ebt Per Ebit	1.0	1.09	1.04	0.95	0.93	0.96	0.88	0.91	0.86	0.82	1.02	0.91	0.72	0.97	1.0
Ebit Per Revenue	0.25	0.28	0.27	0.2	0.26	0.24	0.19	0.21	0.23	0.22	0.19	0.21	0.2	0.38	0.41
Debt Ratio	0.41	0.27	0.22	0.02	0.16	0.21	0.25	0.23	0.21	0.18	0.2	0.26	0.22	0.23	0.25
Debt Equity Ratio	0.11	-	0.03	0.02	0.24	0.35	0.4	0.36	0.32	0.27	0.31	0.42	0.34	0.36	0.46
Long Term Debt To Capitalization	0.1	-	0.03	0.02	0.14	0.21	0.25	0.23	0.2	0.15	0.17	0.25	0.21	0.25	0.29
Total Debt To Capitalization	0.1	-	0.03	0.02	0.19	0.26	0.29	0.27	0.24	0.21	0.24	0.3	0.25	0.26	0.32
Interest Coverage	-	-	-	13.1	13.42	9.37	6.2	8.12	11.08	9.02	4.83	5.26	4.15	57.33	39.58
Cash Flow To Debt Ratio	4.48	-	10.71	12.98	1.54	0.96	0.7	0.74	0.92	1.17	0.81	0.51	0.54	0.61	0.9
Company Equity Multiplier	1.69	1.37	1.27	1.24	1.5	1.63	1.63	1.6	1.57	1.52	1.55	1.65	1.55	1.56	1.85
Receivables Turnover	-	-	-	-	-	-	-	-	32.66	-	-	-	-	-	-
Payables Turnover	-	-	-	5.47	5.06	4.56	5.98	6.77	6.27	6.42	6.78	4.71	4.53	2.66	4.57
Inventory Turn Over	-	-	-	12.73	13.08	12.33	14.41	14.09	15.91	16.62	18.08	15.79	30.55	39.88	54.08
Fixed Asset Turnover	-	-	-	1.02	0.95	0.8	0.75	0.82	0.9	0.91	0.77	0.57	0.62	0.55	0.72
Asset Turnover	0.88	0.85	0.67	0.76	0.74	0.6	0.56	0.6	0.62	0.65	0.55	0.45	0.42	0.31	0.61
Operating Cash Flow Sales Ratio	0.32	0.34	0.34	0.31	0.34	0.34	0.31	0.28	0.3	0.32	0.3	0.29	0.28	0.45	0.37
Free Cash Flow Operating Cash Flow Ratio	0.69	0.8	0.62	0.85	0.55	0.4	0.19	0.11	0.17	0.55	0.72	-0.49	-0.51	-0.46	-0.69
Cash Flow Coverage Ratios	4.48	-	10.71	12.98	1.54	0.96	0.7	0.74	0.92	1.17	0.81	0.51	0.54	0.61	0.9
Short Term Coverage Ratios	-	-	-	72.67	4.76	4.1	4.01	3.87	4.25	3.56	2.42	2.42	2.6	6.91	8.13
Capital Expenditure Coverage Ratio	3.26	4.89	2.62	6.62	2.24	1.67	1.24	1.13	1.21	2.21	3.58	0.67	0.66	0.69	0.59
Dividend Paid And Capex Coverage Ratio	1.27	0.63	2.62	4.28	1.3	1.07	1.03	1.0	1.01	1.52	2.59	0.64	0.59	0.65	0.59
Dividend Payout Ratio	0.62	2	-	0.14	0.45	0.53	0.3	0.19	0.27	0.38	0.19	0.15	0.49	0.11	0.0
Price To Free Cash Flows Ratio, P/FCF	11.68	7.64	10.03	4.73	12.69	12.99	24.34	49.24	63.05	20.62	13.83	-23.78	-33.93	-33110.55	-32.93
Price To Operating Cash Flows Ratio, P/OCF	8.09	6.08	6.2	4.01	7.03	5.2	4.69	5.63	10.9	11.29	9.97	11.6	17.34	15124.53	22.56
Price Cash Flow Ratio, P/CF	8.09	6.08	6.2	4.01	7.03	5.2	4.69	5.63	10.9	11.29	9.97	11.6	17.34	15124.53	22.56
Enterprise Value Multiple, EV	8	6	5	3.34	7.34	6.09	5.71	5.93	11.43	12.9	9.75	12.26	17.89	16339.56	19.12
Price Fair Value, P/FV	4	2	2	1.16	2.62	1.73	1.32	1.5	3.22	3.53	2.53	2.51	3.17	3317.19	9.41

All numbers in RUB currency

Multiples are an important financial analysis tool for the company Мать и Дитя, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios

Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Care facilities industry

Issuer	Price	% 24h	Market Cap	Country
Tenet Healthcare Corporation THC	$ 290.64	0.57 %	$ 26.2 B	USA
SunLink Health Systems SSY	-	17.98 %	$ 7.81 M	USA
Universal Health Services UHS	$ 195.47	-0.86 %	$ 12.4 B	USA
Tivity Health TVTY	-	0.09 %	$ 1.6 B	USA
LHC Group LHCG	-	-	$ 5.27 B	USA
AMN Healthcare Services AMN	$ 37.77	0.16 %	$ 1.45 B	USA
Oak Street Health OSH	-	0.03 %	$ 9.53 B	USA
Ontrak OTRK	-	-11.98 %	$ 1.53 M	USA
Hanger HNGR	-	-	$ 732 M	USA
Novo Integrated Sciences NVOS	-	-13.87 %	$ 1.52 M	USA
American Shared Hospital Services AMS	$ 1.2	-2.44 %	$ 7.94 M	USA
Community Health Systems CYH	$ 2.17	-3.76 %	$ 290 M	USA
Fresenius Medical Care AG & Co. KGaA FMS	$ 22.74	-0.92 %	$ 6.62 B	Germany
Brookdale Senior Living BKD	$ 9.18	-1.4 %	$ 2.16 B	USA
Acadia Healthcare Company ACHC	$ 38.71	0.25 %	$ 3.51 B	USA
Addus HomeCare Corporation ADUS	$ 126.57	3.39 %	$ 2.28 B	USA
Capital Senior Living Corporation CSU	-	-2.09 %	$ 216 M	USA
COMPASS Pathways plc CMPS	$ 9.25	0.76 %	$ 865 M	Britain
Elanco Animal Health Incorporated ELAN	$ 27.0	0.6 %	$ 13.4 B	USA
Concord Medical Services Holdings Limited CCM	$ 3.68	0.55 %	$ 482 M	China
Encompass Health Corporation EHC	$ 142.58	1.01 %	$ 14.3 B	USA
Healthcare Services Group HCSG	$ 25.29	2.06 %	$ 1.83 B	USA
New Frontier Health Corporation NFH	-	3.54 %	$ 1.5 B	USA
The Joint Corp. JYNT	$ 6.84	2.86 %	$ 104 M	USA
MEDNAX MD	$ 31.63	0.44 %	$ 2.66 B	USA
Phibro Animal Health Corporation PAHC	$ 34.64	0.09 %	$ 1.4 B	USA
The Pennant Group PNTG	$ 36.8	1.48 %	$ 1.27 B	USA
Aesthetic Medical International Holdings Group Limited AIH	-	10.96 %	$ 46.2 M	China
Five Star Senior Living Inc. FVE	-	-0.32 %	$ 98.4 M	USA
U.S. Physical Therapy USPH	$ 99.36	-0.48 %	$ 1.51 B	USA
Genesis Healthcare, Inc. GEN	-	-	$ 68.1 M	USA
Avalon GloboCare Corp. AVCO	-	26.45 %	$ 70.6 M	USA
Apollo Medical Holdings AMEH	-	-2.11 %	$ 1.84 B	USA
The Ensign Group ENSG	$ 185.09	1.64 %	$ 10.6 B	USA
Regional Health Properties RHE	-	-	$ 5.2 M	USA
Select Medical Holdings Corporation SEM	-	-	$ 2.02 B	USA
IMAC Holdings IMAC	-	-1.77 %	$ 25.4 M	USA
ModivCare MODV	-	-25.23 %	$ 6.12 M	USA
DaVita DVA	$ 179.27	-3.38 %	$ 13.3 B	USA
HCA Healthcare HCA	$ 504.51	-0.09 %	$ 119 B	USA
Chemed Corporation CHE	$ 544.61	1.22 %	$ 7.84 B	USA
Amedisys AMED	-	0.01 %	$ 3.3 B	USA
ЮМГ GEMC	-	-	-	Russia
National HealthCare Corporation NHC	$ 209.19	-0.26 %	$ 3.24 B	USA
Option Care Health OPCH	$ 31.65	-0.14 %	$ 5.13 B	USA
Surgery Partners SGRY	$ 26.76	1.15 %	$ 3.4 B	USA
Sanara MedTech SMTI	$ 31.66	-1.37 %	$ 273 M	USA

Мать и Дитя Financial Ratios 2025-2011 | MDMG

Brief overview of Мать и Дитя's financial ratios

Overall picture

Annual Financial Ratios Мать и Дитя

Price Earnings Ratio, P/E

Price Sales Ratio, P/S

Price To Book Ratio, P/B

Price Earnings To Growth Ratio, PEG

Operating Cash Flow Per Share

Free Cash Flow Per Share

Cash Per Share

Payout Ratio

Dividend Yield

Current Ratio

Quick Ratio

Cash Ratio

Days Of Sales Outstanding, DSO

Days Of Inventory Outstanding, DIO

Days Of Payables Outstanding, DPO

Operating Cycle

Cash Conversion Cycle

Gross Profit Margin

Operating Profit Margin

Pretax Profit Margin

Net Profit Margin

Effective Tax Rate

Return On Assets, ROA

Return On Equity, ROE

Return On Capital Employed, ROCE

Net Income Per Ebt

Ebt Per Ebit

Ebit Per Revenue

Debt Ratio

Debt Equity Ratio

Long Term Debt To Capitalization

Total Debt To Capitalization

Interest Coverage

Cash Flow To Debt Ratio

Company Equity Multiplier

Receivables Turnover

Payables Turnover

Inventory Turn Over

Fixed Asset Turnover

Asset Turnover

Operating Cash Flow Sales Ratio

Free Cash Flow Operating Cash Flow Ratio

Cash Flow Coverage Ratios

Short Term Coverage Ratios

Capital Expenditure Coverage Ratio

Dividend Paid And Capex Coverage Ratio

Dividend Payout Ratio

Price To Free Cash Flows Ratio, P/FCF

Price To Operating Cash Flows Ratio, P/OCF

Price Cash Flow Ratio, P/CF

Enterprise Value Multiple, EV

Price Fair Value, P/FV

Annual performance

Financial Ratios of other stocks in the Care facilities industry